BioAtla
BCAB
BCAB
39 hedge funds and large institutions have $5.22M invested in BioAtla in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
11
Closed
9
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
+$5K
Top Buyers
Top Sellers
1 |
Morgan Stanley
New York
|
-$111K |
2 |
Squarepoint
New York
|
-$90.3K |
3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$81K |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$78K |
5 |
Two Sigma Advisers
New York
|
-$69.2K |